Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCheckit Regulatory News (CKT)

Share Price Information for Checkit (CKT)

Share Price is delayed by 15 minutes
Get Live Data
21.50    0.00 (0.00%)
Bid:
21.00
Ask:
22.00
Spread: 1.00 (4.762%)
Market Cap: £23.22m
CKT Live PriceLast checked at - London Stock Exchange

Intraday Checkit Share Chart

Contract Wins

12 Jun 2024 07:00

RNS Number : 0440S
Checkit PLC
12 June 2024
 

12 June 2024

 

Checkit plc

("Checkit" or the "Group")

 

Contract Wins

 

Checkit (AIM: CKT), the automated monitoring platform for operational leaders, is pleased to announce a significant expansion with an existing US customer and a first customer for the recently launched AI module.

 

Contract Wins

 

The Group announces a significant expansion with Octaphama Plasma in the United States worth c.£718,000 over three years.

 

Octapharma will be expanding their use of the Checkit platform by integrating TTMUs (Tactical Temperature Monitoring Units) into their existing monitoring system, further protecting their operational data and mission-critical inventory. By leveraging the TTMUs offline data logging capabilities, Octapharma will have complete data redundancy across their entire network of plasma donation centres in the US. The investment highlights Octapharma's ongoing commitment to ensuring the safety and security of their plasma and operational data.

 

The Group is also pleased to announce a first signed contract for the recently launched Asset Intelligence product module, which applies advanced analytics and Machine Learning to IoT data which will help enhance customer sustainability, reduce costs, and improve revenue.

 

Commenting on the news Kit Kyte, Chief Executive Officer, said: "This latest win continues to validate our 'land and expand' strategy and demonstrates continued momentum in the US, a strategic priority for the business. Forward-thinking leaders like Octapharma understand why it's so critical to execute an operational data strategy, and we appreciate their trust and partnership. I am also thrilled that we have secured our first customer for the recently launched Asset Intelligence module, which marks the start of an exciting chapter in the evolution of our offering and our integrated end-to-end platform."

 

For further information, please visit www.checkit.net or contact:

 

Checkit plc

Kit Kyte (Chief Executive Officer)

Greg Price (Chief Financial and Operations Officer)

+44 (0) 1223 643313

Singer Capital Markets (Nominated Adviser & Broker)

Shaun Dobson / Peter Steel / James Fischer

+44 (0) 20 7496 3000

Tavistock (Financial PR)

Lulu Bridges / Katie Hopkins / Simon Hudson

+44 (0) 20 7920 3150

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
CNTFLFITRLILLIS
Date   Source Headline
15th Sep 20107:15 amPRNProposed Cancellation from AIM Close of Offer
15th Sep 20107:00 amRNSOffer Update: Close of Offer
8th Sep 20107:00 amRNSNotification of Interim Results
24th Aug 201011:11 amRNSOffer Document Posted
12th Aug 201012:37 pmRNSDirectorate Change
6th Aug 20102:30 pmRNSDirector/PDMR Shareholding
6th Aug 20102:29 pmRNSHolding(s) in Company
6th Aug 20107:00 amRNSDirectorate Change
6th Aug 20107:00 amRNSHolding(s) in Company
5th Aug 20109:56 amRNSIssue of Equity
2nd Aug 20101:16 pmRNSHolding(s) in Company
30th Jul 20101:00 pmRNSResponse to Offer
30th Jul 20108:45 amRNSForm 8 (OPD) (Hartest Holdings)
30th Jul 20108:37 amRNSOffer for Hartest Holdings
29th Jul 20105:43 pmRNSHolding(s) in Company
29th Jul 20104:00 pmRNSResult of AGM
28th Jul 20107:00 amRNSProposed Issue of Equity
15th Jul 20109:37 amRNSHolding(s) in Company
5th Jul 20103:17 pmRNSAnnual Financial Report
5th Jul 20107:00 amRNSTrading Update
10th Jun 20107:00 amRNSFinal Results
9th Jun 20101:49 pmRNSHolding(s) in Company
19th Apr 20103:45 pmRNSHolding(s) in Company
8th Apr 201012:58 pmRNSHolding(s) in Company
8th Apr 20107:00 amRNSTrading Statement
6th Apr 20107:00 amRNSDirectorate Change
8th Mar 20107:00 amRNSDirectorate Change
22nd Feb 20107:00 amRNSStatement re Possible Offer
19th Feb 201012:18 pmRNSDirector/PDMR Shareholding
16th Feb 20107:00 amRNSDirectorate Change
20th Jan 20103:07 pmRNSDirectorate Change
12th Jan 20107:00 amRNSOffer Update
12th Jan 20107:00 amRNSTrading update
27th Nov 20097:00 amRNSStatement re Possible Offer at 61p
8th Oct 20097:00 amRNSHalf Yearly Report
26th Aug 20094:44 pmRNSStatement re Hartest Holdings plc
19th Aug 20097:00 amRNSTrading Statement
17th Aug 20095:08 pmRNSDirector/PDMR Shareholding
30th Jul 200912:25 pmRNSResult of AGM
22nd Jul 200910:08 amRNSRe scrip dividend alternative
6th Jul 20097:00 amRNSAnnual Financial Report
1st Jul 20095:01 pmPRNStatement re Possible Offer
1st Jul 200911:22 amRNSStatement re Possible Offer
11th Jun 20097:00 amRNSFinal Results
4th Mar 20097:00 amRNSPre Close Trading Update
17th Feb 20092:39 pmRNSDirector/PDMR Shareholding
24th Nov 200812:52 pmRNSDirector/PDMR Shareholding
24th Oct 20084:05 pmRNSHolding(s) in Company
20th Oct 20084:16 pmRNSDirector/PDMR Shareholding
17th Oct 20084:07 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.